Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Business Journal Florida.
Press releases published on September 5, 2025
Syntec Optics (Nasdaq: OPTX) Launches Pioneering New York State Apprenticeship Program to Foster U.S. Advanced Manufacturing
GlobeNewswire
·
September 5, 2025
ROCHESTER, NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (Nasdaq: OPTX) (“Syntec Optics” or the “Company”), a leading provider of technology products to defense, biomedical, communications, and consumer industry leaders, today …
dLocal Announces Closing of Secondary Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
GlobeNewswire
·
September 5, 2025
MONTEVIDEO, Uruguay, Sept. 05, 2025 (GLOBE NEWSWIRE) -- DLocal Limited (“dLocal”), (NASDAQ:DLO) a technology-first payments platform, today announced the closing of a previously announced secondary offering of 17,250,000 Class A common shares (including 2, …
Spyre Therapeutics Announces Grants of Inducement Awards
GlobeNewswire
·
September 5, 2025
WALTHAM, Mass., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, dose optimization and rational therapeutic …
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …
RYVYL Appoints George Oliva and Gene Jones to Its Board of Directors
GlobeNewswire
·
September 5, 2025
- Genevieve Baer and Ezra Laniado resign from the Board of Directors - SAN DIEGO, CA, Sept. 05, 2025 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL) ("RYVYL” or the "Company") has appointed current CFO George Oliva and Gene Jones to its Board of Directors. …
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
BRISBANE, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on September 4, 2025, the Compensation Committee of Vera’s Board of Directors granted inducement awards consisting of non-qualified stock …
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
SAN FRANCISCO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and …
Coherent Joins LLNL’s STARFIRE Diode Technology Working Group to Advance Inertial Fusion Energy
GlobeNewswire
·
September 5, 2025
SAXONBURG, Pa., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, announced today its membership in the Diode Technology Working Group within the STARFIRE Hub, a collaborative initiative led by Lawrence Livermore …
Rapport Therapeutics to Announce Topline Results for RAP-219 Phase 2a Trial in Focal Onset Seizures on Monday, September 8, 2025
GlobeNewswire
·
September 5, 2025
BOSTON and SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for …
Artelo Biosciences Announces Closing of $3.0 Million Public Offering
GlobeNewswire
·
September 5, 2025
SOLANA BEACH, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic …
Fundamental Global Inc. Amends its Charter with the State of Nevada
GlobeNewswire
·
September 5, 2025
Certificate of Amendment Changes Name to FG Nexus Inc., Increases Authorized Shares, Triggers Conversion of Automatic Exercise Pre-Funded Warrants to Common Stock and Expands Outstanding Share Count to Over 35 million Charlotte, NC, Sept. 05, 2025 (GLOBE …
Gyre Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 5, 2025
SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today …
Arvig Launches Digital Life Skills to Boost Digital Literacy, Online Safety for Residents
GlobeNewswire
·
September 5, 2025
PERHAM, Minn., Sept. 05, 2025 (GLOBE NEWSWIRE) -- A high-speed internet connection offers unparalleled opportunities for learning, connection and community impact. Yet, to fully realize its wide-reaching potential, this powerful tool requires one essential …
GSR IV Acquisition Corp. Announces the Closing of its $230 Million Initial Public Offering, Including Full-Exercise Of Over-Allotment Option
GlobeNewswire
·
September 5, 2025
New York, NY, Sept. 05, 2025 (GLOBE NEWSWIRE) -- GSR IV Acquisition Corp. (NASDAQ: GSRF) (“GSRF” or the “Company”) announced today that it closed its initial public offering of 23,000,000 units at a price of $10.00 per unit, for aggregate gross proceeds of …
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on September 1, 2025 the Company granted inducement awards to …
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
REDWOOD CITY, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted inducement awards consisting of non-qualified stock options to …
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or “the Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase …
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
WESTLAKE VILLAGE, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an …
Purple Biotech Announces Closing of Up To $18 Million Public Offering $6 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants
GlobeNewswire
·
September 5, 2025
REHOVOT, Israel, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, …
Spring Valley Acquisition Corp. III Announces Closing of $230 Million Initial Public Offering
GlobeNewswire
·
September 5, 2025
DALLAS, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Spring Valley Acquisition Corp. III (the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business …